Lisa A. Conte, CEO and President of Jaguar Health, Inc. ($JAGX), made one open market purchase of shares worth $0 in the last 365 days, with the most recent on March 31, 2025. She ranks 4,936th out of 4,983 insiders by purchase amount, below the average of $1.46 million across 3.29 transactions. Conte had no open market sales in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 11, 2025 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | See Remarks | A | Stock Option (right to buy) | 28592 | $0.00 | 28,592.0000 | 3,735,837 | 9999.99% | 0.77% |
| Dec. 11, 2025 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | See Remarks | A | Common Stock | 28592 | $0.00 | 29,258.0000 | 3,735,837 | 4293.09% | 0.77% |
| June 24, 2025 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | A | Warrant to Purchase Common Stock | 18262 | $0.00 | 9,000.0000 | 674,043 | 0.00% | 2.71% |
| June 24, 2025 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | D | Convertible Promissory Note | 9000 | $50000.00 | 0.0000 | 674,043 | 100.00% | 1.34% |
| June 24, 2025 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | A | Convertible Promissory Note | 9462 | $50000.00 | 9,462.0000 | 674,043 | 9999.99% | 1.40% |
| May 17, 2025 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | M | Common Stock | 2 | $0.00 | 666.0000 | 674,043 | 0.30% | 0.00% |
| May 17, 2025 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | M | Restricted stock units | 2 | $0.00 | 0.0000 | 674,043 | 100.00% | 0.00% |
| March 31, 2025 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | P | Convertible Promissory Note | 9000 | $50000.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | P | Warrant to Purchase Common Stock | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | See Remarks | A | Common Stock | 16503 | $0.00 | 16,624.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | See Remarks | A | Stock option (right to buy) | 132020 | $0.00 | 132,020.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2024 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | M | Common Stock | 2695 | $0.00 | 7,295.0000 | 0 | 58.59% | 0.00% |
| May 17, 2024 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | M | Restricted stock units | 2695 | $0.00 | 2,694.0000 | 0 | 50.01% | 0.00% |
| April 5, 2024 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | A | Restricted stock units | 600 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 5, 2024 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | M | Common Stock | 600 | $0.00 | 4,600.0000 | 0 | 15.00% | 0.00% |
| Aug. 14, 2023 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | A | Common Stock | 383605 | $0.00 | 387,605.0000 | 0 | 9590.13% | 0.00% |
| May 17, 2023 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | M | Restricted stock units | 2694 | $0.00 | 5,389.0000 | 0 | 33.33% | 0.00% |
| May 17, 2023 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | M | Common Stock | 2694 | $0.00 | 4,000.0000 | 0 | 206.28% | 0.00% |
| April 5, 2023 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | M | Common Stock | 600 | $0.00 | 1,306.0000 | 0 | 84.99% | 0.00% |
| April 5, 2023 | Jaguar Health, Inc. | $JAGX | CONTE LISA A | CEO and President | A | Restricted stock units | 600 | $0.00 | 600.0000 | 0 | 9999.99% | 0.00% |